Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Clinical trial NCT00070382 · COMPLETED

Trial details

NCT number: NCT00070382
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Precancerous/Nonmalignant Condition Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-08-01
Primary completion: 2003-11-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.